Corcept Therapeutics

CORT

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects.

Corcept Therapeutics has been a target of short sellers for a while. The current short interest of 8.69% is roughly at the average of the last 12 months (9.37%).